Clinical trial
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia(APL)
NCT00180128 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia(APL)
- Lead sponsor
- Technische Universität Dresden
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2000
- Completion date
- November 30, 2012
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.